0001628280-22-027577.txt : 20221101 0001628280-22-027577.hdr.sgml : 20221101 20221101163118 ACCESSION NUMBER: 0001628280-22-027577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221101 DATE AS OF CHANGE: 20221101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISARO PAUL CENTRAL INDEX KEY: 0001237253 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 221350882 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 wf-form4_166733465434274.xml FORM 4 X0306 4 2022-10-31 0 0000899923 MYRIAD GENETICS INC MYGN 0001237253 BISARO PAUL 320 WAKARA WAY SALT LAKE CITY UT 84108 1 0 0 0 Common Stock 2022-10-31 4 A 0 16875 0 A 16875 D Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant. By: Justin Hunter For: Paul Bisaro 2022-11-01